NCT00908453View on ClinicalTrials.gov

The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Epilepsy
Interventions
DRUG

fosphenytoin

15mg/kg, 18mg/kg or 22.5mg/kg of loading doses of fosphenytoin

Trial Locations (1)

187-8551

National Center of Neurology and Psychiatry, Kodaira

Sponsors

Lead Sponsor

Nobelpharma
All Listed Sponsors
lead

Nobelpharma

INDUSTRY

NCT00908453 - The Study of NPC-06 - Investigation of Safety, Efficacy and Pharmacokinetics of Fosphenytoin | Biotech Hunter | Biotech Hunter